Fortis Life Sciences
 

Microbiology Product Finder : Clinical

Sector: Clinical

Test type: SARS-CoV-2

Please use both selection boxes below to find companies that supply products in areas that you are interested:

Tick Boxes below to compare products [Max 3]

Status™ COVID-19/Flu A&B, rapid antigen immunoassay

A rapid immunoassay for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, Influenza Type A and Type B antigen from nasopharyngeal swab specimens. Flocked nasopharyngeal swab for superior specimen collection and patient comfort.

Anti-SARS-CoV-2 NeutraLISA

Surrogate virus neutralisation test (sVNT) for determination of neutralising antibodies that inhibit the binding of SARS-CoV-2 S1/RBD to ACE2 receptors

Anti-SARS-CoV-2 QuantiVac ELISA (IgG)

Quantitative ELISA for determination of the concentration of IgG antibodies against the S1 antigen (including RBD) of SARS-CoV-2

EURORealTime SARS-CoV-2

Real-time PCR test for specific detection of SARS-CoV-2, including the variants alpha (B.1.1.7 lineage), beta (B.1.351 lineage), gamma (P.1 lineage), delta (B1.617.2 lineage), lambda (C.37 lineage), mu (B.1.621 lineage) and omicron (B.1.1.529 lineage)

Fapon Biotech RT-PCR Test Solution

Provides the comprehensive reagents, components, materials required to simplify the collection, transport, storage, and detection of SARS-CoV-2. The solution allows biospecimens to be taken from the collection sites and transported to the hospitals and reference labs where viral RNA is extracted and detected by RT-PCR assays. 

Fapon Biotech Antigen Test Solution

The nucleocapsid (N) is a major structural protein of SARS-CoV-2. It is highly conservative, providing an ideal marker for immunodiagnosis. Fapon self-developed monoclonal antibodies have high sensitivity, specificity, and batch-to-batch consistency, with no cross-reactivity with other pathogens (human coronaviruses, flu, pneumonia, etc.). Different application scenarios are supported with stable bulk

COVID-19 Coronavirus and Influenza A/B Virus Real Time PCR Kit

COVID-19 Coronavirus and Influenza A/B virus Real-Time PCR Kit are an In Vitro Diagnostic (IVD) reagent relying on fluorescent PCR technology for the qualitatively detection and differentiation of RNA from SARS-CoV-2, influenza A virus, and/or influenza B virus from upper and lower respiratory tract samples.

Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit

The Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit from Bioperfectus is an in vitro diagnostic test used for the detection of novel coronavirus (SARS-CoV-2) IgM and IgG antibodies. This product is based on immunochromatographic technology. The detection area of the strip has an IgM test line (T2 line),

COVID-19 Coronavirus Real Time PCR Kit

COVID-19 Coronavirus Real-Time PCR Kit is an In Vitro Diagnostic (IVD) reagent applying fluorescent PCR technology and aiming to qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens.  Suitability: Upper

Novel Corona Virus (SARS-CoV-2) Ag Rapid Test

Rapid chromatographic immunoassay (lateral-flow) for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.(Catalog Number: SC30107W)

SARS-CoV-2 IgM ELISA Kit

This kit is used for the qualitative detection of novel coronavirus IgG antibodies in human serum or plasma in vitro. Principle: This kit is based on the capture ELISA method to detect the SARS-COV-2 IgM antibody in human serum or plasma. The anti-µ chain monoclonal antibody is pre-coated

SARS-CoV-2 IgG ELISA Kit

This kit is used for the quantitative detection of novel coronavirus IgG antibodies in human serum or plasma in vitro. Principle: This kit is based on the indirect method (ELISA) principle to detect the SARS-COV-2 IgG antibody in human serum or plasma. The SARS-COV-2 whole virus lysate antigen is

Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike

Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike is used to test the ability of serum, antibodies, and drugs to neutralize the infectivity of SARS-CoV2 spike protein. Pseudovirus display an antigenically-correct spike protein pseudotyped on replication-incompetent virus particles that contain a heterologous lentiviral (HIV) core. Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike is capable of

Proflow™ SARS-CoV-2 Antigen Lateral Flow Test Gives Results in 10 Mins

Proflow™ SARS-CoV-2 Antigen test is designed for the rapid identification of SARS-CoV-2 antigens in human nasopharyngeal swab samples and will provide results in only 10 minutes

PrimeStore® MTM

PrimeStore® MTM is a molecular transport media that gives the user a “snapshot” in time for that sample by preserving and stabilizing DNA and RNA. PrimeStore® MTM (Molecular Transport Medium) was designed and optimized for molecular testing allowing pathogenic samples to be collected, transported,

Rapid test 2019-nCoV Total Immunoglobulins (V1210/V1230)

Rapid test 2019-nCoV Total is a qualitative Lateral Flow test for the determination of IgA, IgM, and IgG antibodies against SARS-CoV-2 in human serum, plasma, or whole blood specimens.

Bio-Shield 2019-nCoV Total Immunoglobulins (C1348/C1396)

Bio-Shield 2019-nCoV Total Immunoglobulins, is a semi-quantitative ELISA test for the determination of IgA, IgM, IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.

Bio-Shield 2019-nCoV IgM (C1248/C1296)

Bio-Shield 2019-nCoV IgM, is a semi-quantitative ELISA test for the determination of IgM antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens

Bio-Shield 2019-nCoV IgG (C1148/C1196)

Bio-Shield 2019-nCoV IgG, is a semi-quantitative ELISA test for the determination of IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens

Suppliers who have products in this sector:

Tick Boxes below to request info [Max 10]
3DMedcare
Abionic
Abwiz Bio
AccessBio
ACON Laboratories, Inc.
Agena Bioscience
altona Diagnostics GmbH
Amerigo Scientific
AMS Biotechnology (Europe) Limited
ANP Technologies
Ansh Labs
Apollo Biomedical LLC
Atila BioSystems
Beijing Applied Biological Technologies
bestbion dx GmbH
BGI Genomics
bioMérieux (Clinical Diagnostics)
BIOTECON Diagnostics GmbH
BNRKorea Co. Ltd
Bosch Healthcare Solutions GmbH
C4Diagnostics
Cepheid
Chembio Diagnostics, Inc.
Clent Life Science
Co-Diagnostics, Inc.
CorDx
Credo Diagnostics Biomedical
Cue Health
DiaSorin Molecular LLC
Diazyme
Ellume
Eurobio Scientific
Eurofins GeneScan Technologies GmbH
EUROIMMUN AG
Everlywell
Fapon Biotech Inc.
Fast Track Diagnostics
Fluidigm
General Biologicals Corporation
GenMark Diagnostics
GenoSensor Corp.
Gnomegen LLC
Guangdong WESAIL Biotech Co., Ltd.
Hardy Diagnostics
HMD Biomedical Inc.
Hologic Inc.
Hybribio Limited
Illumina Inc.
InspectIR Systems, LLC
International Reagent Resource
Jiangsu Bioperfectus Technologies Co., Ltd.
JOYSBIO (Tianjin) Biotechnology Co., Ltd.
Laipac Technology Inc.
LetsGetChecked
LGC-ATCC
Liferiver Biotech
Lucira Health
Luminex Corporation
Luminostics, Inc.
LuminUltra Technologies Ltd.
Meridian Life Science, Inc.
Mesa Biotech, Inc. now part of Thermo Fisher
MicrosensDx
MolGen
nal von minden GmbH
New England Biolabs
NimaGen
Omega Diagnostics Ltd.
OPTOLANE Technologies
Oxford Nanopore Technologies
PerkinElmer Inc.
Phase Scientific
Pinpoint Science
Premier Medical Corporation
Primerdesign Ltd
Pro-Lab Diagnostics
ProGnosis Biotech S.A
ProtonDx Ltd.
Quest Diagnostics
Quidel Corporation
R-Biopharm AG
Rapid Labs Ltd.
Roche Diagnostics
RTA Laboratories/Dianova
Sartorius AG
Scanwell Health
ScienCell Laboratories
SD Biosensor
Sense Biodetection Limited
Siemens Healthineers
Sino Biological US Inc.
Sona Nanotech Inc.
Stilla Technologies Inc.
The Gold Standard Diagnostics Group
VIROTECH Diagnostics GmbH
Vivera Pharmaceuticals
Wuhan EasyDiagnosis Biomedicine Co., Ltd